BCM
IONS icon

BlueCrest Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

BlueCrest Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-23,370
Closed -$1.53M – 203
2025
Q3 		$1.53M Buy
+23,370
New +$1.14M 0.03% 129
2025
Q2 		– Sell
-24,800
Closed -$748K – 122
2025
Q1 		$748K Sell
24,800
-1,400
-5% -$45.8K 0.03% 64
2024
Q4 		$916K Buy
+26,200
New +$979K 0.03% 77
2019
Q2 		– Sell
-34,935
Closed -$2.84M – 739
2019
Q1 		$2.84M Buy
34,935
+15,092
+76% +$974K 0.11% 136
2018
Q4 		$1.07M Buy
19,843
+9,343
+89% +$477K 0.06% 202
2018
Q3 		$542K Buy
+10,500
New +$493K 0.01% 715
2017
Q3 		– Sell
-27,706
Closed -$1.41M – 970
2017
Q2 		$1.41M Buy
27,706
+16,215
+141% +$755K 0.05% 402
2017
Q1 		$462K Buy
11,491
+6,894
+150% +$310K 0.02% 448
2016
Q4 		$220K Sell
4,597
-9,211
-67% -$364K 0.01% 593
2016
Q3 		$506K Buy
+13,808
New +$432K 0.02% 524
2016
Q1 		– Sell
-14,633
Closed -$906K – 945
2015
Q4 		$906K Buy
+14,633
New +$790K 0.04% 436
2015
Q3 		– Sell
-17,414
Closed -$1M – 943
2015
Q2 		$1M Buy
+17,414
New +$1.11M 0.03% 498
2015
Q1 		– Sell
-4,387
Closed -$271K – 685
2014
Q4 		$271K Buy
+4,387
New +$216K 0.01% 503

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

BlueCrest Capital Management's IONS Position: Q4 2025 in Review

BlueCrest Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q4 2025, closing a stake of 23,370 shares — an estimated $1.53M sold.

BlueCrest Capital Management first reported a position in IONS in Q4 2014 and held it in 13 quarters. The position peaked at $2.84M in Q1 2019. 491 funds tracked by Wall St. Rank hold IONS as of Q4 2025.

  • BlueCrest Capital Management reported no remaining Ionis Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • BlueCrest Capital Management sold 23,370 Ionis Pharmaceuticals shares in Q4 2025, an estimated $1.53M.
  • BlueCrest Capital Management first reported a position in Ionis Pharmaceuticals in Q4 2014 and held it in 13 quarters.
  • BlueCrest Capital Management's Ionis Pharmaceuticals position peaked at $2.84M in Q1 2019.
  • 491 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2025.

Based on BlueCrest Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.